Reuters logo
BRIEF-GSK CEO says to decide future of Lucozade, Ribena by mid-year
February 6, 2013 / 12:45 PM / 5 years ago

BRIEF-GSK CEO says to decide future of Lucozade, Ribena by mid-year

LONDON, Feb 6 (Reuters) - GlaxoSmithKline Plc : * CEO says all options on table for Lucozade and Ribena * CEO says aims to conclude Lucozade and Ribena review by mid-2013 * CEO says has very low appetite for acquisitions * CEO says has very much focused on organic growth * CEO declines to comment in detail on job impact of latest restructuring * CEO says much of change in research and development, manufacturing involves

new processes rather than job cuts * CEO says likely to be some job losses in Europe due to pricing pressures * CEO says looking for commercialisation partner for new diabetes drug albiglutide

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below